Healthtech Startups

Naviday Health builds a platform that captures real-world health data from consumer devices and wearables and integrates it into clinical decision-making. The company focuses on women's health, starting with menopause management and planning to expand to cardiovascular risk and chronic care.

3 investors

Navidence offers a platform for health research teams to build Computable Operational Definitions (CODefs) that standardize data definitions for study design and fit-for-purpose real-world data assessment. It supports precision and consistency in turning health data into evidence and helps teams meet regulatory expectations from bodies such as the FDA and ICH.

3 investors

Neatsy Health offers remote orthopedic care, connecting patients and their families to orthopedic surgeons and physical therapists through telehealth subscriptions. Its patient app uses smartphone camera-based AI computer vision to monitor movement and generate personalized recovery exercise programs for musculoskeletal pain and injuries.

3 investors

Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field. The company operates in the medical device and biotech space.

3 investors

Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

3 investors

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.

3 investors

Neon Health builds AI workers that automate pharma patient-access workflows such as benefit verification, prior authorization, denials and appeals, financial assistance enrollment, patient onboarding, and adherence support. It serves pharma hubs and healthcare access teams, aiming to reduce contact-center labor costs and speed time-to-therapy.

3 investors

NephroPlus is India's largest dialysis service provider offering hemodialysis, home and mobile dialysis, and pharmacy and wellness services across India, Nepal, the Philippines, and Uzbekistan. The company operates 490 clinics using a scalable, asset-light model and serves over 33,000 patients annually.

3 investors

Neru Health provides an AI-powered operations platform for durable medical equipment (DME) suppliers to automate patient onboarding, compliance management, therapy adherence monitoring, and equipment resupply workflows. The platform integrates with existing DME software and clinical systems to reduce operating costs and improve patient outcomes.

3 investors

Nest Collaborative provides telehealth lactation services through online video appointments with International Board-Certified Lactation Consultants (IBCLCs), supporting parents through breastfeeding and infant feeding. Its services are offered seven days a week, accepted by most commercial insurance plans, and available in multiple languages for families in the US.

3 investors

Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.

3 investors

Net Health provides clinical intelligence and specialty software solutions for healthcare organizations delivering wound care, rehabilitation therapy, occupational health, and skilled nursing services.

3 investors

Neteera develops contactless sensor-based technology for continuous patient monitoring, using AI and signal processing to support clinical workflows and remote care. It sells to healthcare providers, including in the North American market.

3 investors

Neue Health operates a value-based healthcare platform serving hundreds of thousands of people across the ACA Marketplace, Medicare, and Medicaid through owned clinics and partnerships with independent providers. The company aligns incentives between health consumers, providers, and payors to deliver coordinated, affordable, high-quality care.

3 investors

Neuroclues develops eye-tracking technology to identify neurological disorders including Parkinson's, Alzheimer's, and Multiple Sclerosis before symptoms appear, serving clinicians and healthcare practitioners. The company combines hardware, software, and cloud systems to provide biomarkers for early disease detection.

3 investors

Neuronetics manufactures and sells the NeuroStar Advanced Therapy System, a transcranial magnetic stimulation device used in office-based treatment of major depressive disorder and other mental health conditions, along with operating a network of treatment centers that provide both NeuroStar therapy and esketamine treatment to patients.

3 investors

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

3 investors

Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions. The company serves health systems, health plans, and clinical providers seeking to screen for mild cognitive impairment before symptom progression.

3 investors

Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders. The company conducts research and development activities supported by European funding programs.

3 investors

NeuroX1 is an Austin-based biotech building a generative-AI target ID and drug discovery platform for neurological disorders.

3 investors

New View Medical develops single-use surgical visualization devices designed for minimally invasive procedures. The company targets healthcare systems seeking to reduce costs while improving clinical outcomes.

3 investors

NewDays offers a clinician-supervised cognitive treatment program combining telehealth support with AI-guided brain training exercises, designed for individuals with mild cognitive impairment or dementia. The program is delivered at home and aims to improve cognitive function, mental health, and delay symptom progression.

3 investors

Newton's Tree is an AI orchestration and deployment platform for hospitals that helps health systems select, test, deploy, and monitor AI products as managed infrastructure. It offers a vendor-neutral AI marketplace, sandbox performance testing, workflow integration via standards like DICOM, HL7v2, and FHIR, and continuous monitoring, serving health systems across the US, UK, and Europe.

3 investors

NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor. Its pipeline of first-in-class immuno-oncology assets is aimed at cancer patients with B7-H7 upregulation, including those who do not respond to existing PD-1/L1 inhibitor therapies.

3 investors